AMICUS THERAPEUTICS INC. - COMMON STOCK

Amicus Therapeutics Announces Third Quarter 2022 Financial Results and Corporate Updates

07 ноя 2022 06:00:01 Источник Nasdaq GlobeNewswire

U.S. FDA Defers Action on Filing for AT-GAA in Late-onset Pompe Disease

28 окт 2022 15:01:00 Источник Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Third Quarter 2022 Financial Results on November 7, 2022

27 окт 2022 06:00:01 Источник Nasdaq GlobeNewswire

Amicus Therapeutics Announces Participation at World Muscle Society 2022

11 окт 2022 06:00:00 Источник Nasdaq GlobeNewswire

Amicus Therapeutics Announces Participation at the 2022 AANEM Annual Meeting

21 сен 2022 06:00:00 Источник Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

08 сен 2022 06:00:01 Источник Nasdaq GlobeNewswire

Amicus Therapeutics Announces Second Quarter 2022 Financial Results

04 авг 2022 06:00:03 Источник Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Second Quarter 2022 Financial Results on August 4, 2022

26 июл 2022 06:00:00 Источник Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference

08 июн 2022 06:00:01 Источник Nasdaq GlobeNewswire

Amicus Therapeutics Receives Notification of PDUFA Date Extensions for AT-GAA

10 май 2022 15:01:00 Источник Nasdaq GlobeNewswire

CORRECTING AND REPLACING -- Amicus Therapeutics Announces First Quarter 2022 Financial Results

09 май 2022 08:15:35 Источник Nasdaq GlobeNewswire

Amicus Therapeutics Announces First Quarter 2022 Financial Results

09 май 2022 06:00:01 Источник Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Bank of America 2022 Healthcare Conference

04 май 2022 06:00:02 Источник Nasdaq GlobeNewswire

Amicus Therapeutics to Announce First Quarter 2022 Financial Results on May 9, 2022

26 апр 2022 06:00:00 Источник Nasdaq GlobeNewswire

Amicus Announces Issuance of New U.S. Composition of Matter Patent for Galafold® (migalastat), Strengthening Patent Protection Through 2038

19 апр 2022 06:00:01 Источник Nasdaq GlobeNewswire

Amicus Therapeutics Announces Positive Long-Term Data from Phase 1/2 Study of AT-GAA in Pompe Disease at the 2022 MDA Clinical & Scientific Conference

16 мар 2022 06:00:01 Источник Nasdaq GlobeNewswire

Amicus Therapeutics Announces Presentation and Posters at the 2022 MDA Clinical & Scientific Conference

10 мар 2022 06:00:01 Источник Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Cowen 42nd Annual Health Care Conference

01 мар 2022 06:00:02 Источник Nasdaq GlobeNewswire

Amicus Therapeutics Announces Full-Year 2021 Financial Results and Corporate Updates

24 фев 2022 06:00:02 Источник Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Full-Year 2021 Financial Results on February 24, 2022

10 фев 2022 06:00:02 Источник Nasdaq GlobeNewswire